These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 15665806

  • 1. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
    Stuerenburg HJ, Ganzer S, Müller-Thomsen T.
    Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806
    [Abstract] [Full Text] [Related]

  • 2. Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects.
    Maccioni RB, Lavados M, Guillón M, Mujica C, Bosch R, Farías G, Fuentes P.
    Neurobiol Aging; 2006 Feb; 27(2):237-44. PubMed ID: 16399209
    [Abstract] [Full Text] [Related]

  • 3. Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.
    Hansson O, Zetterberg H, Buchhave P, Andreasson U, Londos E, Minthon L, Blennow K.
    Dement Geriatr Cogn Disord; 2007 Feb; 23(5):316-20. PubMed ID: 17374949
    [Abstract] [Full Text] [Related]

  • 4. Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.
    Hansson O, Buchhave P, Zetterberg H, Blennow K, Minthon L, Warkentin S.
    Neurobiol Aging; 2009 Feb; 30(2):165-73. PubMed ID: 17646035
    [Abstract] [Full Text] [Related]

  • 5. Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment.
    Zhong Z, Ewers M, Teipel S, Bürger K, Wallin A, Blennow K, He P, McAllister C, Hampel H, Shen Y.
    Arch Gen Psychiatry; 2007 Jun; 64(6):718-26. PubMed ID: 17548753
    [Abstract] [Full Text] [Related]

  • 6. Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?
    Palumbo B, Siepi D, Sabalich I, Tranfaglia C, Parnetti L.
    Funct Neurol; 2008 Jun; 23(2):93-6. PubMed ID: 18671910
    [Abstract] [Full Text] [Related]

  • 7. CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment.
    Stefani A, Martorana A, Bernardini S, Panella M, Mercati F, Orlacchio A, Pierantozzi M.
    J Neurol Sci; 2006 Dec 21; 251(1-2):124-8. PubMed ID: 17097109
    [Abstract] [Full Text] [Related]

  • 8. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.
    Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Bouwman F, Venturelli E, Guidi I, Blankenstein MA, Bresolin N, Scarpini E.
    Arch Neurol; 2006 Apr 21; 63(4):538-43. PubMed ID: 16606766
    [Abstract] [Full Text] [Related]

  • 9. Concentration of 5-hydroxyindoleacetic acid, homovanillic acid, and tryptophan in the cerebrospinal fluid of depressed patients before and after ECT.
    Abrams R, Essman WB, Taylor MA, Fink M.
    Biol Psychiatry; 1976 Feb 21; 11(1):85-90. PubMed ID: 1260078
    [Abstract] [Full Text] [Related]

  • 10. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
    Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Mathé AA.
    J Clin Psychopharmacol; 2010 Oct 21; 30(5):496-503. PubMed ID: 20814316
    [Abstract] [Full Text] [Related]

  • 11. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A, García JC, Fernández R, Fernández Cartaya L.
    Bol Estud Med Biol; 1993 Oct 21; 41(1-4):13-9. PubMed ID: 7521168
    [Abstract] [Full Text] [Related]

  • 12. CSF cortisol in Alzheimer's disease and mild cognitive impairment.
    Popp J, Schaper K, Kölsch H, Cvetanovska G, Rommel F, Klingmüller D, Dodel R, Wüllner U, Jessen F.
    Neurobiol Aging; 2009 Mar 21; 30(3):498-500. PubMed ID: 17716786
    [Abstract] [Full Text] [Related]

  • 13. Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study.
    Morimoto S, Takao M, Hatsuta H, Nishina Y, Komiya T, Sengoku R, Nakano Y, Uchino A, Sumikura H, Saito Y, Kanemaru K, Murayama S.
    PLoS One; 2017 Mar 21; 12(2):e0171524. PubMed ID: 28166276
    [Abstract] [Full Text] [Related]

  • 14. Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment?
    Leoni V, Shafaati M, Salomon A, Kivipelto M, Björkhem I, Wahlund LO.
    Neurosci Lett; 2017 Mar 21; 397(1-2):83-7. PubMed ID: 16406316
    [Abstract] [Full Text] [Related]

  • 15. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL, Moreno FA, Kling MA, Anderson GM, Regenold WT, Labiner DM, Price LH.
    Biol Psychiatry; 2004 Sep 15; 56(6):418-26. PubMed ID: 15364040
    [Abstract] [Full Text] [Related]

  • 16. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
    Vaughn DM, Coleman E, Simpson ST, Satjawatcharaphong C.
    Am J Vet Res; 1988 Aug 15; 49(8):1302-6. PubMed ID: 2459997
    [Abstract] [Full Text] [Related]

  • 17. Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study.
    Lewczuk P, Kornhuber J, Vanderstichele H, Vanmechelen E, Esselmann H, Bibl M, Wolf S, Otto M, Reulbach U, Kölsch H, Jessen F, Schröder J, Schönknecht P, Hampel H, Peters O, Weimer E, Perneczky R, Jahn H, Luckhaus C, Lamla U, Supprian T, Maler JM, Wiltfang J.
    Neurobiol Aging; 2008 Jun 15; 29(6):812-8. PubMed ID: 17239996
    [Abstract] [Full Text] [Related]

  • 18. Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.
    Höglund K, Hansson O, Buchhave P, Zetterberg H, Lewczuk P, Londos E, Blennow K, Minthon L, Wiltfang J.
    Neurodegener Dis; 2008 Jun 15; 5(5):268-76. PubMed ID: 18309230
    [Abstract] [Full Text] [Related]

  • 19. Laboratory examinations correlated with severity of dementia.
    Oishi M, Mochizuki Y, Yoshihashi H, Takasu T, Nakano E.
    Ann Clin Lab Sci; 1996 Jun 15; 26(4):340-5. PubMed ID: 8800434
    [Abstract] [Full Text] [Related]

  • 20. Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease.
    Popp J, Bacher M, Kölsch H, Noelker C, Deuster O, Dodel R, Jessen F.
    J Psychiatr Res; 2009 May 15; 43(8):749-53. PubMed ID: 19038405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.